論文- 髙木 清司 -
表示方法: 表示形式: 表示順:
件数:87件
[2019]
1.Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells..[Clinical & experimental metastasis,36(5),(2019),423-432]Iwabuchi E, Miki Y, Onodera Y, Shibahara Y, Takagi K, Suzuki T, Ishida T, Sasano H
10.1007/s10585-019-09981-2
http://www.ncbi.nlm.nih.gov/pubmed/31222613
2.<i>ESR1</i>-stabilizing lncRNA <i>TMPO-AS1</i> promotes hormone-refractory breast cancer progression..[Molecular and cellular biology,(2019)]Mitobe Y, Ikeda K, Suzuki T, Takagi K, Kawabata H, Horie-Inoue K, Inoue S
10.1128/MCB.00261-19
http://www.ncbi.nlm.nih.gov/pubmed/31501276
3.Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma..[Histology and histopathology,(2019),18130-]Sato A, Takagi K, Miki Y, Yoshimura A, Hara M, Ishida T, Sasano H, Suzuki T
10.14670/HH-18-130
http://www.ncbi.nlm.nih.gov/pubmed/31149728
[2018]
4.OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma..[Cancer science,109(10),(2018),3350-3359]Mayama A, Takagi K, Suzuki H, Sato A, Onodera Y, Miki Y, Sakurai M, Watanabe T, Sakamoto K, Yoshida R, Ishida T, Sasano H, Suzuki T
10.1111/cas.13770
http://www.ncbi.nlm.nih.gov/pubmed/30137688
5.Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer..[International journal of molecular sciences,19(8),(2018)]Fue M, Miki Y, Takagi K, Hashimoto C, Yaegashi N, Suzuki T, Ito K
10.3390/ijms19082438
http://www.ncbi.nlm.nih.gov/pubmed/30126180
6.The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma..[Molecular and cellular endocrinology,466,(2018),31-37]Takagi K, Miki Y, Ishida T, Sasano H, Suzuki T
10.1016/j.mce.2017.09.011
http://www.ncbi.nlm.nih.gov/pubmed/28918115
7.17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer..[International journal of molecular sciences,19(4),(2018)]Hashimoto C, Miki Y, Tanaka S, Takagi K, Fue M, Doe Z, Li B, Yaegashi N, Suzuki T, Ito K
10.3390/ijms19041139
http://www.ncbi.nlm.nih.gov/pubmed/29642629
8.ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens..[International journal of molecular sciences,19(3),(2018)]Takagi K, Miki Y, Onodera Y, Ishida T, Watanabe M, Sasano H, Suzuki T
10.3390/ijms19030804
http://www.ncbi.nlm.nih.gov/pubmed/29534468
9.The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion..[Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,33(1),(2018),26-33]Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, Takagi K, Mizumoto S, Yamada S, van Kuppevelt TH, Yokoyama A, Matsusaka T, Sato H, Ito S, Sugawara A
10.1093/ndt/gfx218
http://www.ncbi.nlm.nih.gov/pubmed/28992095
[2017]
10.Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis..[Cancer science,108(7),(2017),1510-1519]Chishiki M, Takagi K, Sato A, Miki Y, Yamamoto Y, Ebata A, Shibahara Y, Watanabe M, Ishida T, Sasano H, Suzuki T
10.1111/cas.13251
http://www.ncbi.nlm.nih.gov/pubmed/28394473
11.Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment..[Breast cancer research : BCR,19(1),(2017),70-]Sakurai M, Miki Y, Takagi K, Suzuki T, Ishida T, Ohuchi N, Sasano H
10.1186/s13058-017-0863-0
http://www.ncbi.nlm.nih.gov/pubmed/28629450
12.p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation..[Cancer medicine,6(6),(2017),1264-1274]Nakayama S, Karasawa H, Suzuki T, Yabuuchi S, Takagi K, Aizawa T, Onodera Y, Nakamura Y, Watanabe M, Fujishima F, Yoshida H, Morikawa T, Sase T, Naitoh T, Unno M, Sasano H
10.1002/cam4.1093
http://www.ncbi.nlm.nih.gov/pubmed/28544335
13.Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer..[International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,27(4),(2017),643-650]Tsuji K, Utsunomiya H, Miki Y, Hanihara M, Fue M, Takagi K, Nishimoto M, Suzuki F, Yaegashi N, Suzuki T, Ito K
10.1097/IGC.0000000000000995
http://www.ncbi.nlm.nih.gov/pubmed/28375930
[2016]
14.CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance..[Cancer Sci,107(12),(2016),1898-1908]Minemura, Hiroyuki Takagi, Kiyoshi Sato, Ai Takahashi, Hikaru Miki, Yasuhiro Shibahara, Yukiko Watanabe, Mika Ishida, Takanori Sasano, Hironobu Suzuki, Takashi
10.1111/cas.13081
http://www.ncbi.nlm.nih.gov/pubmed/27627783
15.TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation..[Cancer Med,5(8),(2016),1973-1982]Onodera, Yoshiaki Takagi, Kiyoshi Miki, Yasuhiro Takayama, Ken-Ichi Shibahara, Yukiko Watanabe, Mika Ishida, Takanori Inoue, Satoshi Sasano, Hironobu Suzuki, Takashi
10.1002/cam4.736
http://www.ncbi.nlm.nih.gov/pubmed/27333920
16.Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-lambda2 or IL-29/IFN-lambda1..[Cancer Gene Ther,23(8),(2016),266-277]Hasegawa, K Tagawa, M Takagi, K Tsukamoto, H Tomioka, Y Suzuki, T Nishioka, Y Ohrui, T Numasaki, M
10.1038/cgt.2016.29
http://www.ncbi.nlm.nih.gov/pubmed/27561689
17.Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration..[Histol Histopathol,(2016),11799]Katagiri, Munetoshi Karasawa, Hideaki Takagi, Kiyoshi Nakayama, Shun Yabuuchi, Shinichi Fujishima, Fumiyoshi Naitoh, Takeshi Watanabe, Mika Suzuki, Takashi Unno, Michiaki Sasano, Hironobu
10.14670/HH-11-799
http://www.ncbi.nlm.nih.gov/pubmed/27363977
18.Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration..[Endocr J,63(3),(2016),287-299]Takagi, Kiyoshi Miki, Yasuhiro Tanaka, Sota Hashimoto, Chiaki Watanabe, Mika Sasano, Hironobu Ito, Kiyoshi Suzuki, Takashi
10.1507/endocrj.EJ15-0490
http://www.ncbi.nlm.nih.gov/pubmed/26842712
[2015]
19.Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor..[Cancer Sci,106(11),(2015),1642-1650]Minemura, Hiroyuki Takagi, Kiyoshi Miki, Yasuhiro Shibahara, Yukiko Nakagawa, Saki Ebata, Akiko Watanabe, Mika Ishida, Takanori Sasano, Hironobu Suzuki, Takashi
10.1111/cas.12808
http://www.ncbi.nlm.nih.gov/pubmed/26331797
20.一般外科学 乳癌におけるアンドロゲン作用 あらたな治療対象の可能性.[医学のあゆみ,254(12),(2015),1132-1133]鈴木 貴 高木 清司
Page: [1] [2] [3] [4] [5] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University